Table 1.
Correlation between FAM53A expression and clinicopathological characteristics of invasive breast cancer.
| Clinicopathological feature | N | FAM53A | P-value | |
|---|---|---|---|---|
| Positive | Negative | |||
| All cases | 199 | 70 | 129 | |
| Age (years) | ||||
| ≤50 | 105 | 36 | 69 | 0.781 |
| >50 | 94 | 34 | 60 | |
| Tumor size | ||||
| ≤5.0 cm | 92 | 27 | 65 | 0.110 |
| >5.0 cm | 107 | 43 | 64 | |
| TNM stage | ||||
| I/II | 109 | 32 | 77 | 0.056 |
| III | 90 | 38 | 52 | |
| Lymph node metastasis | ||||
| Negative | 119 | 42 | 77 | 0.996 |
| Positive | 80 | 28 | 52 | |
| p53 status | ||||
| Negative | 115 | 53 | 62 | <0.001 |
| Positive | 84 | 17 | 67 | |
| ER, PR, and HER-2 Status | ||||
| Non-TNBC | 176 | 58 | 118 | 0.069 |
| TNBC | 23 | 12 | 11 | |
TNBC, triple-negative breast cancer; ER, estrogen receptor; PR, progesterone receptor.